
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.66966
Pathology
Dentistry
Oncology
Decoding Oral Carcinogenesis and Tumor Progression in Whole Cigarette Smoke Exposure: A Systematic Review
Muacevic Alexander
Adler John R
Li Jiao 12
Ab Rahman Nurhayu 3
Mohamad Suharni 4
1 Pathology, School of Dental Sciences, Universiti Sains Malaysia Health Campus, Kubang Kerian, MYS
2 Pathology, Changzhi Medical College, Shanxi, CHN
3 Oral Medicine and Oral Pathology Unit, School of Dental Sciences, Universiti Sains Malaysia Health Campus, Kubang Kerian, MYS
4 Oral and Maxillofacial Diseases Research Cluster, School of Dental Sciences, Universiti Sains Malaysia Health Campus, Kubang Kerian, MYS
Nurhayu Ab Rahman nurhayu@usm.my
15 8 2024
8 2024
16 8 e6696615 8 2024
Copyright © 2024, Li et al.
2024
Li et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/282883-decoding-oral-carcinogenesis-and-tumor-progression-in-whole-cigarette-smoke-exposure-a-systematic-review
This systematic review aims to highlight the molecular mechanisms by which whole cigarette smoke affects oral carcinogenesis and its progression in human oral cells, based on evidence from original research articles published in the literature. A literature search was conducted using three databases: Web of Science, Scopus, and PubMed from May to June 2024. The articles were screened, and the data were extracted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines (2020). The included studies were subsequently evaluated using the Systematic Review Center for Laboratory Animal Experimentation (SYRCLE) tool for bias factors. From the 14 included studies, two types of cell lines were frequently utilized: human oral mucosal epithelial cells or oral squamous cell carcinoma cells. In these cell lines, one of three forms of exposure was applied: cigarette smoke, its extract, or condensate. The mechanism of oral carcinogenesis and tumor progression includes aberrations in the heme metabolic pathway, modulation of miRNA-145, NOD1 and BiP expression, MMP-2, MMP-9, and cathepsin modulation, abnormal TSPO binding, RIP2-mediated NF-κB activation, MZF1-mediated VEGF binding, and activation of the RAGE signaling pathway. In conclusion, cigarette smoke significantly influences the development and progression of oral squamous cell carcinoma, based on the evidence highlighted in human oral cells. While previous studies have focused on specific carcinogens and pathways, this review added to our understanding of the overall impact of whole cigarette smoke on oral carcinogenesis at the molecular and cellular levels.

oral squamous cell carcinoma
signaling pathways
human oral cells
cigarette smoke
oral carcinogenesis
Universiti Sains Malaysia Research University Grant (1001/PPSG/8012345) provided funds for Cureus article processing charges/ Preferred Editing Service
==== Body
pmcIntroduction and background

Oral squamous cell carcinoma (OSCC) is the most prevalent type of head and neck squamous cell carcinoma (HNSCC), ranked as the sixth most common cancer in the world [1]. According to Global Cancer Statistics (2020), lip and oral cavity cancer are highly frequent in South Central Asia (e.g., India, Sri Lanka, and Pakistan) as well as Melanesia (Papua New Guinea) [1]. The primary risk factor for OSCC is tobacco smoking, which is three times more likely in smokers than nonsmokers. Other risk factors include betel quid (BQ) chewing, alcohol consumption, and poor dietary habits lacking fruits and vegetables. Additionally, it is estimated that only 3% of OSCC prevalence is related to high-risk human papillomavirus (HR-HPV) infection, compared to more than 90% of oropharyngeal squamous cell carcinoma (OPSCC) cases [2-5]. Despite breakthroughs in medical technology and treatment protocols, the five-year overall OSCC survival rate remains at 65% [6]. Therefore, it is crucial to understand the evidence-based mechanisms underlying the development of cigarette-related OSCC to implement effective preventive healthcare strategies fully.

According to accumulating evidence, cigarette smoke produces over 5,000 distinct chemical constituents, of which over 60 are carcinogenic [7]. In this regard, the International Agency for Research on Cancer (IARC) has reviewed several carcinogens, including nitrosamines, polyaromatic aromatic hydrocarbon (PAH), aromatic amines, aldehydes, phenols, volatile hydrocarbons, nitro compounds, and other organic and inorganic substances. Among which, nitrosamines mainly comprise N′-nitrosonornicotine (NNN) and 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK), while PAH mainly contains Benzo[a]pyrene (B[a]p), DB[a,l]P: Dibenzo [def,p]chrysene (Dibenzo[a,l]pyrene, DB[a,l]P). Animal or human research provided sufficient evidence for each of the discovered carcinogens. For example, B[a]p, NNK, and NNN are group 1 carcinogens, while DB[a,l]P and acrolein are group 2A carcinogens [8]. It is established that these tobacco-derived carcinogens give rise to the development of lung, oral, nose, larynx, oropharynx, hypopharynx, esophagus, stomach, liver, pancreas, bladder, kidney, and cervical cancers, as well as myeloid leukemia [9-17]. Nicotine, the primary component of cigarette smoke, is also extremely addictive. The ability of nicotine to cause cancer per se has been a subject of debate for several decades [18]. Some studies have demonstrated that nicotine causes cancer in A/J mice and epithelial cells in culture, suggesting that it should be designated as a carcinogen [19-23].

Indeed, research on the specific carcinogenic constituents in cigarettes is essential in understanding the underlying mechanism of cigarette smoke-related oral carcinogenesis, as mentioned in previous studies. However, no study has systematically reviewed the evidence on how whole cigarette smoke affects the molecular mechanisms of oral carcinogenesis or its progression. A number of studies have investigated the role that whole cigarette smoke plays in the development of oral carcinogenesis and OSCC. In oral mucosal epithelial cells, cigarette smoke extract (CSE) has been shown to have the potential to suppress nucleotide-binding oligomerization domain 1 (NOD1) expression and modify the expression levels of critical molecules in the NOD1 signaling pathway. This process facilitates the recruitment and activation of receptor-interacting protein 2 (RIP2), which in turn activates nuclear factor κB (NF-κB) and starts the transcription of downstream genes [24]. CSE can also enhance OSCC cell invasion in a way that is dependent on the advanced glycation end-products (RAGE) activation pathway [25].

The goal of this study was to delineate the molecular mechanism induced by whole cigarette smoke exposure in the development or progression of OSCC using data from human-derived oral cell line studies.

Review

Materials and methods

A systematic literature search was conducted from May to June 2024 on the Web of Science, Scopus, and PubMed (Medline) databases. The population, intervention, comparator and outcomes (PICO) framework served as the basis for the inclusion and exclusion criteria.

The inclusion criteria were original research articles in the English language that fulfilled the following requirements, namely, (1) P: Studies based on the research on human oral cell lines; (2) I: The cells were cultured and exposed to any form of whole cigarette smoke; (3) C: The availability of a control group against test group for comparison; (4) O: The outcomes that demonstrated the molecular mechanism on oral carcinogenesis or its progression.

The following criteria were used to omit studies: reviews, letters, editorial material, book chapters, conference abstracts, clinical studies, in vivo studies, animal studies, and non-English language articles.

The preliminary search strategies can be seen in Appendix 1.

Additionally, studies were excluded if they lacked sufficient evidence to link cigarette smoke to oral carcinogenesis or the progression of OSCC. For instance, studies where cigarette smoke only caused inflammatory responses or showed no significant difference between control and treatment groups were not considered.

The screening and selection of articles were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [26]. Both investigators (JL and NAR) double-checked the results. Each study’s title and abstract were reviewed. Subsequently, the identified studies underwent eligibility and cross-referencing screening. All related articles published from the beginning of the database’s records up to June 2024 were considered for inclusion. Endnote v20.4 (Clarivate Plc, Philadelphia, PA) was used for the screening procedure, utilizing its built-in "check for duplicates" feature to eliminate redundant research. The number of duplicate hits in each database and the overall number of hits based on the search outputs were noted. After meeting the inclusion criteria, abstracts were pulled for additional screening before obtaining the full-text papers. 

From each of the included papers, the surname of the first author, the year the study was conducted, the cell line utilized in the investigation, the interventions, and the outcome findings were extracted. Additionally, the corresponding authors of the included studies were contacted directly in case any information was missing.

Study Quality and Risk of Bias Assessment

For animal research, the Cochrane risk of bias tool was adjusted for bias factors unique to animal intervention studies using the Systematic Review Center for Laboratory Animal Experimentation (SYRCLE) tool [27]. Additionally, because there was currently no well-recognized, standardized risk of bias instrument for in vitro research, the SYRCLE tool was also utilized for in vitro cell model investigations [28]. The SYRCLE tool evaluated selection bias (associated with sequence generation, baseline characteristics, and allocation concealment), performance bias, detection bias, attrition bias, reporting bias, and other kinds of bias. The majority opinion determined the total SYRCLE risk of bias tool score, which was classified as high, low, or indeterminate. A minimal risk of bias across all evaluated domains was considered a sign of a high-quality study.

Results

A total of 2,898 preliminary articles were identified in accordance with the search, selection, and evaluation outlined in the method section (Figure 1).

Figure 1 PRISMA 2020 flow diagram for new systematic reviews.

Three databases were searched: Web of Science, PubMed, and Scopus.

A total of 14 articles met the inclusion and exclusion criteria and were added to the qualitative synthesis in this review (Table 1).

Table 1 Characteristics of the included studies

Abbreviation: CS, cigarette smoke; CSE, cigarette smoke extract; CSC, cigarette smoke condensate; NOD1, nucleotide-binding oligomerization-domain 1; miRNA, micro-RNA; MMP, matrix metalloproteinase (MMP); TSPO, translocator protein 18kDa; RIP2, receptor-interacting protein 2; NF-κB, nuclear factor κB; MZF1, myeloid zinc finger 1; VFGF, vascular endothelial growth factor (VEGF); BiP, binding immunoglobulin protein; miR-30a, miRNA-30a (miR-30a); OSCC, oral squamous cell carcinoma; RAGE, receptor for advanced glycation end-products

Author,  Year	Type of human-derived cell lines	Form of CS exposure	Outcome	
Gao et al., 2015 [24]	Oral mucosal epithelial cells (Leuk-1)	CSE	CSE could inhibit NOD1 expression and affect expression levels of crucial molecules of NOD1 signaling in oral mucosal epithelial cells.	
Chapman et al., 2018 [25]  	OSCC cells (Ca9-22)  	CSE	CSE increased invasion of OSCC cells in a RAGE-dependent manner. Inhibition of RAGE decreases the levels of its signaling molecules, which results in blocking the CS extract-induced invasion.	
Gavish et al., 2017 [29]	SCC-15	CS	A rapid decrease in TSPO binding to the high-affinity site induced by exposure to CS	
Nagler et al., 2015 [30]	SCC-25 SCC-15  	CS	SCC-15 cells showed a 70% (p<0.05) increase in apoptotic levels immediately after 30 min of exposure to CS. Twenty-four hours after 30-min CS exposure a further increase in apoptotic levels to 178% (p<0.05);  SCC-15 cells showed a decrease in apoptotic levels immediately after 180-min exposure to CS. SCC-25 cells did not show such CS-related effects.	
Nagler et al., 2010 [31]	SCC-25 SCC-15	CS	TSPO binding decreased by 56% and 72%, in the SCC-25 and SCC-15 cell lines, respectively (p<0.05) following CS exposure. 	
Krayzler et al (b)., 2015 [32]	SCC-25 SCC-15	CS	SCC-15: At 60 and 90 min, increases in the pre-G(1) cell fraction were noted at 118% (p<0.05) and 135% (p<0.01) respectively. The G(2)/M cell fraction was significantly lower following CS exposure. At 90 and 120 min following CS exposure, the G(2)/M fraction levels had declined by 44% (p<0.05) and 34% (p<0.01) respectively. SCC-25: At 90 and 120 min following CS exposure, the pre-G(1) fraction of the cells increased by 230% and 550%, respectively (p<0.01). At 120 min of CS exposure, the fraction of G(2)/M cells was lower by 47% (p<0.05) compared to controls.	
Krayzler et al (a)., 2015 [33]	SCC-25 SCC-15	CS	Protein oxidation increased significantly during CS exposure. Carbonyl levels increased six-fold (p<0.001) in both cell lines. Cell viability decrease was time-dependent. Longer CS exposure led to higher cell mortality. At 120 min, SCC-25 cell survival reduction was 43.7%, (p<0.01). Propidium iodide (PI) assay results matched the Trypan blue assay showing a time-dependent cell viability decrease following CS exposure. At 120 min, cell survival reduction was 37% (p<0.05). 	
Sarkar et al., 2019 [34]	Oral keratinocyte cell  (MOE1A)	CSE	CSE alters mitochondrial heme metabolic pathway and initiates cancer progression through modifying cellar biomarkers in oral epithelial cells.	
Qian et al., 2022 [35]	OSCC cell lines (HSC-3)	CSE	CSE-induced RIP2 mediated NF-κB activation and caspase-12 upregulation	
Krueger et al., 2020 [36]	OSCC cells (HNSCCUM-02T)	CSE	MZF1 binding of VEGF-promoter; directly affects VEGF-gene regulation under CSE exposure.	
Pal et al., 2013 [37]	Oral fibroblasts 	CSC	Pri-, pre-, and mature miRNA-145 were significantly down-regulated in response to CSC, and this was accompanied by up-regulated expression of MMP-2 and increased migration of fibroblasts compared to untreated controls.	
Nagaraj et al., 2007 [38]	686Tu 101A	CSC	Treatment of OSCC cells (686Tu and 101A) with CSC-activated cathepsins B, D, and L in a dose-dependent manner. 	
Allam et al., 2011 [39]	SCC-25 CAL-27	CSC	Exposure to CSC increased the collagen degrading ability of the SCC-25 by a mechanism involving increased MMP-2 and MMP-9 production.	
Chien et al., 2021 [40]	OSCC cells (YD38 and SCC25)  	CSC	CSC increased the expression of BiP in time- and dose-dependent manners in YD38 and SCC25 cells; silencing BiP abrogated CSC-induced cell invasion and tumor-associated angiogenesis; CSC increased the expression of BiP in OSCC cells by downregulating miR-30a. BiP promoted invasion and tumor-associated angiogenesis by increasing the production and secretion of VEGF in CSC-exposed OSCC cells.	

The risk of bias evaluation for each of the 14 studies is summarized in Figure 2. No section of any article was considered high risk.

Figure 2 Risk of bias assessed by the Systematic Review Center for Laboratory Animal Experimentation (SYRCLE) guidelines.

(A) A graphic summary of the evaluations of the 14 articles that were included. (B) An overview of each article's ratings according to the SYRCLE domains. Some domains displayed unclear risk of bias due to insufficient information available.

Study Characteristics

The included studies were conducted within the time frame of 2007 to 2022. Out of 14, five studies used whole cigarette smoke exposure [29-33], another five studies used CSE [24, 25, 34-36], and four studies used cigarette smoke condensate (CSC) [37-40]. The cell lines used in the studies were as follows: three studies used normal oral mucosa epithelial cells, i.e., oral keratinocyte cells (MOE1A) [34], oral mucosal epithelial cells (Leuk-1) [24], and oral fibroblasts [37]. The remaining 11 studies utilized OSCC cells to investigate the impact of cigarette smoke on OSCC progression. The most commonly selected cell lines include SCC15, SCC25, CAL-27, HSC-3, Ca9-22, HNSCCUM-02T, 686Tu, and YD38.

The mechanism of oral carcinogenesis and tumor progression demonstrated by these studies includes aberrations in the heme-metabolic pathway, modulation of miRNA-145, NOD1 and BiP expression, MMP-2, MMP-9, and cathepsin modulation, abnormal TSPO binding, RIP2-mediated NF-κB activation, MZF1-mediated VEGF binding, and activation of the receptor for advanced glycation end-products (RAGE) signaling pathway.

Discussion

According to published research, cigarette smoke contains a variety of carcinogenic substances that cause oral cancer. Nevertheless, it is unclear how cancer develops and progresses when human oral cells are exposed to whole cigarette smoke. The most widely accepted mechanism connecting cigarette smoke to the progression of cancer is the production of excess reactive oxygen species (ROS) [41], which raises mitochondrial dysfunction and metabolic activity [42]. The synthesis of heme is connected to the metabolic activity of mitochondria. It has been demonstrated that exposure to CSE leads to increased levels of ROS, initiates heme catabolism-inducing HO-1 gene expression, and triggers the epithelial-mesenchymal transition (EMT) process in oral epithelial cells (MOE1A) via the Nrf2/HO-1 pathway [34]. These incidents could be a factor in the spread of oral cancer. ROS have paradoxical effects on cancer: low ROS levels promote cancer cell proliferation, while high ROS levels induce cell death [43]. This systematic review highlights ROS's role in oral carcinogenesis. High ROS levels reduced cell viability in MOE1A cells over 24 hours and increased apoptosis in SCC-15 cells after 30 minutes and 24 hours of exposure. Surprisingly, SCC-25 cells did not show similar cigarette smoke-related effects [30, 34]. However, Krayzler et al. [33] reported reduced cell survival in SCC-25 cells under cigarette smoke exposure (120 minutes) in the same experimental context as Nagler et al. [30]. This discrepancy may arise from differences in the cell viability test methods used.

Furthermore, cell cycle analysis revealed that cigarette smoke exposure significantly increases the proliferation rate of SCC-15 and SCC-25 cells [32]. This effect is attributed to the 18 kDa translocator protein (TSPO), which significantly influences the proliferation of various cancer cells [29]. TSPO knockdown has been shown to disrupt mitochondrial function in hepatocellular carcinoma (HCC) by increasing ROS production and lowering mitochondrial membrane potential (ΔΨm), which in turn inhibited HCC cell proliferation [44]. When lung cancer cells (H1299) were exposed to cigarette smoke, TSPO expression was upregulated, and a series of biological events leading to cell death were initiated [45]. The knockdown of TSPO can induce apoptosis and inhibit proliferation, as shown in research utilizing anti-sense TSPO knockdown methods to down-regulate TSPO in MA-10 Leydig tumor cells, which resulted in increased tumorigenicity both in vivo and in vitro [46]. In addition, researchers have utilized various techniques for TSPO knockdown and different types of TSPO ligands to reduce apoptotic rates through the mitochondrial apoptosis cascade mechanism [47, 48]. According to Nagler et al. (2010), there was a clear link between lower patient survival rates and increased TSPO expression in oral cancer tissue [31]. However, after cigarette smoke exposure, TSPO binding decreased in the SCC-25 and SCC-15 cell lines [29, 31]. This indicates that cigarette smoke exposure affects TSPO binding differently in specific cell lines. This requires further studies to elucidate the underlying mechanisms and to explore the potential implications for oral carcinogenesis and therapeutic interventions.

As tumors grow beyond a certain size, they require oxygen and nutrients for continued growth, invasion, and metastasis [49]. Angiogenesis is critical in this process, and one important component is the vascular endothelial growth factor (VEGF) [50]. According to the study by Chien et al. (2021), BiP promoted VEGF production and secretion in OSCC cells (YD38 and SCC25) after CSC exposure, mediated by miR-30a. This resulted in tumor invasion and angiogenesis [40]. Another study showed that nicotine, one of the primary cigarette smoke constituents, activated the YAP-TEAD transcriptional complex, which in turn induced BiP expression and caused malignant behaviors such as invasion, migration, and changes in EMT [51]. It was worth noting that MZF1 binding of VEGF-promoter directly influences VEGF-gene regulation in HNSCCUM-02T cells exposed to CSE, and this effect may be more significant in OSCC than in lung cancer cells. [36].

In addition to VEGF, pattern-recognition cell-surface RAGE also shows increased expression during exposure to second-hand smoke [52]. Studies have demonstrated that RAGE plays an important role in the invasion of OSCC [53]. Chapman et al. (2018) reported that CSE could increase the invasion of OSCC cells (Ca9-22) through activation of the RAGE signaling pathway [25]. Specifically, it mediates signaling intermediates Ras, AKT, and NF-κB, which is consistent with findings by Sanders et al. (2017) [54]. Additionally, it regulated matrix metalloproteinases MMP-2, MMP-9, and MMP-14, and upregulation of these resulted in collagen degradation and tumor invasion. Allam et al. (2011) showed a similar result regarding CSC-induced upregulation of MMPs (MMP-2 and MMP-9), which was observed in SCC-25 cells but not in CAL-27 cells [39]. The authors hypothesized that this difference in response could be attributed to the origin of the cell lines: SCC-25, derived from a metastasizing tongue lesion, and CAL-27, derived from a non-metastasizing tongue lesion. Consequently, CSC treatment appears to have a more significant impact on the behavior of metastasizing tongue SCC than non-metastasizing tongue SCC [39]. However, the impact of RAGE signaling following cigarette smoke exposure in Ca9-22 cells derived from human gingival carcinoma remains unclear [25]. Additionally, CSC-induced upregulation of MMP-2 was also detected in oral fibroblasts due to down-regulation of pri-, pre-, and mature miRNA-145 [37]. These findings suggest that the RAGE-MMPs axis and RAGE/ Ras, AKT, and NF-κB pathway may play a pivotal role in cigarette smoke-induced oral carcinogenesis and tumor progression.

Other than MMPs, activation of cathepsins B or L may have been involved in the increased invasion of CSC-treated cells. Administration of these inhibitors prevented cancer cells from invading. It has been shown that cathepsins B and L were crucial in matrix degradation and cell invasion [55-57]. Moreover, cigarette smoke was known to activate TNF-α, probably via cathepsins B mediated TNF-α-induced tumor cell death [38]. Cathepsins B and L were identified as the two main factors that influenced the invasive growth of CSC-treated OSCC cells (686Tu and 101A) [38]. This effect probably resulted from the cytochrome P450 enzymes CYP1A1 and CYP1B1 breaking down carcinogens into compounds that attach to TNF-α receptors [58].

Another pathway implicated in cigarette smoke-induced oral carcinogenesis involves the nuclear factor κB (NF-κB) signaling pathway, where receptor-interacting protein 2 (RIP2) plays a crucial role in regulating inflammatory and cell death processes [59]. RIP2 is also a predictive biomarker and therapeutic target, and it plays a role in the development, spread, and metastasis of various tumor types. [60, 61]. In OSCC cells (HSC-3), cigarette smoke may upregulate the RIP2/caspase-12/NF-κB axis [35]. This finding is in line with earlier research, which found that cigarette smoke increased the expression of RIP2 in mouse lung tissues and RIP2 gene silencing could lessen acute lung injury [62].

In summary, we explore three key mechanisms underlying cigarette smoke-related oral carcinogenesis and progression in human oral cells. First, cigarette smoke exposure triggers increased ROS levels via the HO-1 - EMT - Nrf2/HO-1 pathway, impacting adaptability in cancer cells. Second, TSPO influences cellular proliferation and apoptosis in specific OSCC cell lines, suggesting that TSPO dysfunction could play a role in the development of OSCC. Third, whole cigarette smoke exposure contributes to tumor growth and progression through angiogenesis (VEGF regulation), elevated BiP expression (linked to nicotine activation of the YAP-TEAD complex), and the RAGE signaling pathway (involving intermediates Ras, AKT, and NF-κB). Additionally, MMPs play a role in collagen degradation, while cathepsins mediate cigarette smoke-activated TNF-α. The upregulation of the RIP2/caspase-12/NF-κB axis impacts inflammatory processes and cell death. Consequently, targeting RIP2 pharmacologically may offer a strategy to control the development of cigarette smoke-related OSCC. Further studies are required to determine this approach’s feasibility, assess its efficacy, and ensure its safety in clinical settings.

Conclusions

We highlighted various mechanisms of cigarette smoke-induced oral carcinogenesis and tumor progression in human oral cells. Based on the evidence, we concluded that cigarette smoke significantly influences the development and progression of OSCC. While previous studies have focused on specific carcinogens and pathways, this review enhanced our understanding of the overall impact of whole CS on oral carcinogenesis at the molecular and cellular levels. However, further research is needed to elucidate specific mechanisms by which cigarette smoke contributes to OSCC development.

Disclosures

Author Contributions

Appendices

Table 2 outlines the preliminary search strategy method utilized in the study. 

Table 2 The preliminary search strategy method

The search method combined free words, Boolean search strings, and medical topic headings (MeSH keywords) when available.

 The preliminary search strategy method	
P: ("Squamous Cell Carcinoma of Head and Neck"[Mesh]) OR (“Oral Squamous Cell Carcinoma”[Title/Abstract]) OR (“Oral Cavity Squamous Cell Carcinoma”[Title/Abstract]) OR (“Oral Tongue Squamous Cell Carcinoma”[Title/Abstract]) OR (“Squamous Cell Carcinoma of the Mouth”[Title/Abstract]) OR (“OSCC”[Title/Abstract]) OR ("Mouth Neoplasms"[Mesh]) OR (“Oral Neoplasm”[Title/Abstract]) OR (“Oral Cancer”[Title/Abstract]) OR (“Mouth Cancer”[Title/Abstract])	
AND	
I: ("Tobacco Products"[Mesh]) OR (“Cigarette*” [Title/Abstract]) OR (“Bidi*” [Title/Abstract]) OR (“Kretek*” [Title/Abstract])) OR (“Cigar*” [Title/Abstract]) OR (“Pipe Tobacco*” [Title/Abstract]) OR (“Cigarillo*”[Title/Abstract]) OR (“Tobacco Product*”[Title/Abstract])	
NOT	
("Electronic Nicotine Delivery Systems"[Mesh]) OR (“Electronic Cigarettes” [Title/Abstract]) OR (“E-Cig*” [Title/Abstract]) OR (“E-Cigarette*” [Title/Abstract]) OR (“Electronic Cigarette” [Title/Abstract])	
NOT	
("Tobacco Smokeless"[Mesh]) OR (“Smokeless Tobacco”[Title/Abstract]) OR (“Tobaccos Smokeless”[Title/Abstract])) OR (“Gutka*”[Title/Abstract]) OR (“Gutka Tobacco*”[Title/Abstract]) OR (“Snus”[Title/Abstract]) OR (“Dipping Tobacco*”[Title/Abstract]) OR (“Oral Tobacco”[Title/Abstract]) OR (“Chewing Tobacco*”[Title/Abstract]) OR (“Snuff”[Title/Abstract]) OR (“Mint Snuff”[Title/Abstract])	
NOT	
("Vaping"[Mesh]) OR (“THC Vaping*” [Title/Abstract]) OR (“E-Cig Use” [Title/Abstract])) OR (“Vape*” [Title/Abstract])) OR (“Nicotine Vaping*” [Title/Abstract])	

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: Universiti Sains Malaysia Research University Grant (1001/PPSG/8012345) provided funds for Cureus article processing charges/ Preferred Editing Service.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Nurhayu Ab Rahman, Jiao Li, Suharni Mohamad

Acquisition, analysis, or interpretation of data:  Nurhayu Ab Rahman, Jiao Li

Drafting of the manuscript:  Nurhayu Ab Rahman, Jiao Li

Critical review of the manuscript for important intellectual content:  Nurhayu Ab Rahman, Jiao Li, Suharni Mohamad

Supervision:  Nurhayu Ab Rahman, Suharni Mohamad
==== Refs
References

1 Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin Sung H Ferlay J Siegel RL Laversanne M Soerjomataram I Jemal A Bray F 209 249 71 2021 33538338
2 Tobacco smoking and cancer: a meta-analysis Int J Cancer Gandini S Botteri E Iodice S Boniol M Lowenfels AB Maisonneuve P Boyle P 155 164 122 2008 17893872
3 Detection of human papillomavirus in oropharyngeal squamous cell carcinoma J Zhejiang Univ Sci B Fauzi FH Hamzan NI Rahman NA Suraiya S Mohamad S 961 976 21 2020 33843162
4 Smokeless tobacco and cancer Lancet Oncol Boffetta P Hecht S Gray N Gupta P Straif K 667 675 9 2008 18598931
5 World Cancer Report: Cancer Research for Cancer Prevention Wild CP Weiderpass E Stewart BW (eds) Lyon International Agency for Research on Cancer 2020 https://publications.iarc.fr/586
6 Cancer statistics, 2019 CA Cancer J Clin Siegel RL Miller KD Jemal A 7 34 69 2019 30620402
7 Tobacco Smoke and Involuntary Smoking (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 83) IARC Monogr Eval Carcinog Risks Hum IARC Working Group on the Evaluation of Carcinogenic Risks to Humans 1 1438 Lyon International Agency for Research on Cancer 83 2004 https://www.ncbi.nlm.nih.gov/books/NBK316407/ 15285078
8 WHO: Agents Classified by the IARC Monographs, Volumes 1-136 8 2024 2022 https://monographs.iarc.who.int/agents-classified-by-the-iarc/
9 (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats Carcinogenesis Balbo S James-Yi S Johnson CS 2178 2183 34 2013 23671129
10 Tobacco smoke exposure and the risk of childhood acute lymphoblastic leukemia and acute myeloid leukemia: A meta-analysis Medicine (Baltimore) Chunxia D Meifang W Jianhua Z Ruijuan Z Xiue L Zhuanzhen Z Linhua Y 0 98 2019
11 Diallyl trisulfide inhibited tobacco smoke-mediated bladder EMT and cancer stem cell marker expression via the NF-κB pathway in vivo J Int Med Res Geng H Guo W Feng L 300060521992900 49 2021 33730908
12 Tobacco and alcohol as risk factors for pancreatic cancer Best Pract Res Clin Gastroenterol Korc M Jeon CY Edderkaoui M Pandol SJ Petrov MS 529 536 31 2017 29195672
13 Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma Mol Cancer Li W Zhang L Guo B 22 18 2019 30736860
14 Small-cell lung cancer Nat Rev Dis Primers Rudin CM Brambilla E Faivre-Finn C Sage J 3 7 2021 33446664
15 Correction: Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway J Exp Clin Cancer Res Xie C Zhu J Wang X 141 42 2023 37277842
16 Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine Chem Res Toxicol Zhang S Wang M Villalta PW Lindgren BR Lao Y Hecht SS 949 956 22 2009 19405515
17 Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans Genome Res Zhivagui M Ng AW Ardin M 521 531 29 2019 30846532
18 Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis Mutat Res Catassi A Servent D Paleari L Cesario A Russo P 221 231 659 2008 18495523
19 Nicotine induces DNA damage in human salivary glands Toxicol Lett Ginzkey C Kampfinger K Friehs G Köhler C Hagen R Richter E Kleinsasser NH 1 4 184 2009 18852035
20 Assessment of nicotine-induced DNA damage in a genotoxicological test battery Mutat Res Ginzkey C Friehs G Koehler C Hackenberg S Hagen R Kleinsasser NH 34 39 751 2013 23200805
21 Analysis of nicotine-induced DNA damage in cells of the human respiratory tract Toxicol Lett Ginzkey C Stueber T Friehs G 23 29 208 2012 22001448
22 Muscle sarcomas and alopecia in A/J mice chronically treated with nicotine Life Sci Galitovskiy V Chernyavsky AI Edwards RA Grando SA 1109 1112 91 2012 22521759
23 Novel pathways and mechanisms of nicotine-induced oral carcinogenesis Recent Pat Anticancer Drug Discov Sharma M Shetty SS Radhakrishnan RA 66 79 17 2022 34365933
24 NOD1 agonist iE-DAP reverses effects of cigarette smoke extract on NOD1 signal pathway in human oral mucosal epithelial cells Int J Clin Exp Med Gao Y Jiang W Qian Y Zhou Q Jiang H Wang X Wang W 12519 12528 8 2015 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612847/ 26550162
25 Cigarette smoke extract induces oral squamous cell carcinoma cell invasion in a receptor for advanced glycation end-products-dependent manner Eur J Oral Sci Chapman S Mick M Hall P 33 40 126 2018 29226456
26 The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ Page MJ McKenzie JE Bossuyt PM 0 372 2021
27 SYRCLE's risk of bias tool for animal studies BMC Med Res Methodol Hooijmans CR Rovers MM de Vries RB Leenaars M Ritskes-Hoitinga M Langendam MW 43 14 2014 24667063
28 The role of hypoxia-associated miRNAs in acquired sensorineural hearing loss Front Cell Neurosci Safabakhsh S Wijesinghe P Nunez M Nunez DA 916696 16 2022 35990888
29 Two populations of TSPO binding sites in oral cancer SCC-15 cells Exp Cell Res Gavish A Krayzler E Nagler R 279 283 350 2017 27939322
30 DNA fragmentation induced by cigarette smoke in oral cancer cells Cancer Genomics Proteomics Nagler RM Krayzler E Veenman L Gavish M 77 81 12 2015 https://cgp.iiarjournals.org/content/12/2/77.long 25770191
31 Oral cancer, cigarette smoke and mitochondrial 18kDa translocator protein (TSPO) - In vitro, in vivo, salivary analysis Biochim Biophys Acta Nagler R Ben-Izhak O Savulescu D 454 461 1802 2010 20085808
32 Cigarette smoke-induced effects on the cell cycle in oral cancer cells: reduction of G2/M fraction Cancer Genomics Proteomics Krayzler E Nagler RM 73 76 12 2015 https://cgp.iiarjournals.org/content/12/2/73.long 25770190
33 Carbonyl levels and survival rates in oral cancer cells exposed to cigarette smoke Anticancer Res Krayzler E Nagler RM 1961 1965 35 2015 https://ar.iiarjournals.org/content/35/4/1961.long 25862848
34 Effect of cigarette smoke extract on mitochondrial heme-metabolism: An in vitro model of oral cancer progression Toxicol In Vitro Sarkar R Kishida S Kishida M 336 346 60 2019 31247333
35 Cigarette smoking induces the activation of RIP2/caspase-12/NF-κB axis in oral squamous cell carcinoma PeerJ Qian Y Wang W Chen D Zhu Y Wang Y Wang X 0 10 2022
36 Cigarette smoke modulates binding of the transcription factor MZF1 to the VEGF promoter and regulates VEGF expression in dependence of genetic variation SNP 405 J Oral Pathol Med Krüger M Metzger C Al-Nawas B Kämmerer PW Brieger J 780 786 49 2020 32449233
37 Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145 J Oral Pathol Med Pal A Melling G Hinsley EE Kabir TD Colley HE Murdoch C Lambert DW 309 314 42 2013 23173553
38 Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells Toxicol Lett Nagaraj NS Zacharias W 134 145 170 2007 17399918
39 Effects of cigarette smoke condensate on oral squamous cell carcinoma cells Arch Oral Biol Allam E Zhang W Al-Shibani N Sun J Labban N Song F Windsor LJ 1154 1161 56 2011 21489402
40 Dysregulation of the miR-30a/BiP axis by cigarette smoking accelerates oral cancer progression Cancer Cell Int Chien CY Chen YC Lee CH 578 21 2021 34717640
41 Mitochondria in health, disease, and aging Physiol Rev Harrington JS Ryter SW Plataki M Price DR Choi AM 2349 2422 103 2023 37021870
42 Dihydrotanshinone triggers Porimin-dependent oncosis by ROS-mediated mitochondrial dysfunction in non-small-cell lung cancer Int J Mol Sci Zhang D Yuan R Pan J 11953 24 2023 37569328
43 The relationship of redox with hallmarks of cancer: the importance of homeostasis and context Front Oncol Xing F Hu Q Qin Y Xu J Zhang B Yu X Wang W 862743 12 2022 35530337
44 TSPO is a novel biomarker for prognosis that regulates cell proliferation through influencing mitochondrial functions in HCC Heliyon Pan JH Kang YQ Li Q 0 9 2023
45 Effects of cigarette smoke on TSPO-related mitochondrial processes Cells Zeineh N Nagler R Gabay M Weizman A Gavish M 694 8 2019 31295884
46 Peripheral benzodiazepine receptor antisense knockout increases tumorigenicity of MA-10 Leydig cells in vivo and in vitro Biochemistry Weisinger G Kelly-Hershkovitz E Veenman L Spanier I Leschiner S Gavish M 12315 12321 43 2004 15379570
47 VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis J Bioenerg Biomembr Veenman L Shandalov Y Gavish M 199 205 40 2008 18670869
48 CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells Biochemistry Zeno S Zaaroor M Leschiner S Veenman L Gavish M 4652 4661 48 2009 19358520
49 Angiogenic signaling pathways and anti-angiogenic therapy for cancer Signal Transduct Target Ther Liu ZL Chen HH Zheng LL Sun LP Shi L 198 8 2023 37169756
50 Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy Clin Cancer Res Patel SA Nilsson MB Le X Cascone T Jain RK Heymach JV 30 39 29 2023 35969170
51 YAP-dependent BiP induction is involved in nicotine-mediated oral cancer malignancy Cells Chien CY Chen YC Hsu CC 2080 10 2021 34440849
52 Antenatal exposure of maternal secondhand smoke (SHS) increases fetal lung expression of RAGE and induces RAGE-mediated pulmonary inflammation Respir Res Winden DR Barton DB Betteridge BC 129 15 2014 25338658
53 Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma Oncology Bhawal UK Ozaki Y Nishimura M 246 255 69 2005 16127291
54 Cigarette smoke extract (CSE) induces RAGE-mediated inflammation in the Ca9-22 gingival carcinoma epithelial cell line Arch Oral Biol Sanders NT Dutson DJ Durrant JW 95 100 80 2017 28399471
55 Cathepsin B: A sellsword of cancer progression Cancer Lett Mijanović O Branković A Panin AN Savchuk S Timashev P Ulasov I Lesniak MS 207 214 449 2019 30796968
56 Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells J Med Invest Nomura T Katunuma N 1 9 52 2005 15751268
57 Lysosomal peptidases in innate immune cells: implications for cancer immunity Cancer Immunol Immunother Jakoš T Pišlar A Pečar Fonović U Kos J 275 283 69 2020 31813053
58 Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells Toxicol Lett Nagaraj NS Beckers S Mensah JK Waigel S Vigneswaran N Zacharias W 182 194 165 2006 16713138
59 The diverse roles of RIP kinases in host-pathogen interactions Semin Cell Dev Biol Eng VV Wemyss MA Pearson JS 125 143 109 2021 32859501
60 RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma Aging (Albany NY) Li D Tang L Liu B Xu S Jin M Bo W 10450 10467 13 2021 33790054
61 Autophagy regulatory genes MET and RIPK2 play a prognostic role in pancreatic ductal adenocarcinoma: a bioinformatic analysis based on GEO and TCGA Biomed Res Int Li X Li Z Zhu H Yu X 8537381 2020 2020 33204717
62 Gene silencing of receptor-interacting protein 2 protects against cigarette smoke-induced acute lung injury Pharmacol Res Dong J Liao W Tan LH Yong A Peh WY Wong WS 560 568 139 2019 30394320
